Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Sonja Loges, Bjorn Torre Gjertsen, Michael Heuser, I Ben-Batalla, David Micklem, Chromik Jorg, Maxim Kebenko, Walter M. Fiedler, Jorge E. Cortes | ||||||||||||
Title | A first-in-patient phase I study of BGB324, a selective Axl kinase inhibitor in patients with refractory/relapsed AML and high-risk MDS. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/170403-176 | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 2561) |